These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Differential role of NR2A and NR2B subunits in N-methyl-D-aspartate receptor antagonist-induced aberrant cortical gamma oscillations. Kocsis B Biol Psychiatry; 2012 Jun; 71(11):987-95. PubMed ID: 22055014 [TBL] [Abstract][Full Text] [Related]
5. Differential effects of NMDA receptor antagonists at lower and higher doses on basal gamma band oscillation power in rat cortical electroencephalograms. Hiyoshi T; Kambe D; Karasawa J; Chaki S Neuropharmacology; 2014 Oct; 85():384-96. PubMed ID: 24907590 [TBL] [Abstract][Full Text] [Related]
6. Aberrant alpha and gamma oscillations ex vivo after single application of the NMDA receptor antagonist MK-801. Lemercier CE; Holman C; Gerevich Z Schizophr Res; 2017 Oct; 188():118-124. PubMed ID: 28109667 [TBL] [Abstract][Full Text] [Related]
7. Ketamine Alters Lateral Prefrontal Oscillations in a Rule-Based Working Memory Task. Ma L; Skoblenick K; Johnston K; Everling S J Neurosci; 2018 Mar; 38(10):2482-2494. PubMed ID: 29437929 [TBL] [Abstract][Full Text] [Related]
8. Ketamine induced converged synchronous gamma oscillations in the cortico-basal ganglia network of nonhuman primates. Slovik M; Rosin B; Moshel S; Mitelman R; Schechtman E; Eitan R; Raz A; Bergman H J Neurophysiol; 2017 Aug; 118(2):917-931. PubMed ID: 28468999 [No Abstract] [Full Text] [Related]
9. Opposite Modulation of the NMDA Receptor by Glycine and S-Ketamine and the Effects on Resting State EEG Gamma Activity: New Insights into the Glutamate Hypothesis of Schizophrenia. Haaf M; Curic S; Rauh J; Steinmann S; Mulert C; Leicht G Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768234 [TBL] [Abstract][Full Text] [Related]
10. Alterations in interhemispheric gamma-band connectivity are related to the emergence of auditory verbal hallucinations in healthy subjects during NMDA-receptor blockade. Thiebes S; Steinmann S; Curic S; Polomac N; Andreou C; Eichler IC; Eichler L; Zöllner C; Gallinat J; Leicht G; Mulert C Neuropsychopharmacology; 2018 Jun; 43(7):1608-1615. PubMed ID: 29453445 [TBL] [Abstract][Full Text] [Related]
11. Ketamine Alters Functional Gamma and Theta Resting-State Connectivity in Healthy Humans: Implications for Schizophrenia Treatment Targeting the Glutamate System. Curic S; Andreou C; Nolte G; Steinmann S; Thiebes S; Polomac N; Haaf M; Rauh J; Leicht G; Mulert C Front Psychiatry; 2021; 12():671007. PubMed ID: 34177660 [TBL] [Abstract][Full Text] [Related]
12. Alterations in High-Frequency Neuronal Oscillations in a Cynomolgus Macaque Test of Sustained Attention Following NMDA Receptor Antagonism. Goonawardena AV; Heiss J; Glavis-Bloom C; Trube G; Borroni E; Alberati D; Wallace TL Neuropsychopharmacology; 2016 Apr; 41(5):1319-28. PubMed ID: 26354045 [TBL] [Abstract][Full Text] [Related]
13. Beta and Gamma Oscillations in Prefrontal Cortex During NMDA Hypofunction: An In Vitro Model of Schizophrenia Features. Rebollo B; Perez-Zabalza M; Ruiz-Mejias M; Perez-Mendez L; Sanchez-Vives MV Neuroscience; 2018 Jul; 383():138-149. PubMed ID: 29723576 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of acute and chronic administration of ketamine on hippocampal oscillations: relevance for the NMDA receptor hypofunction model of schizophrenia. Kittelberger K; Hur EE; Sazegar S; Keshavan V; Kocsis B Brain Struct Funct; 2012 Apr; 217(2):395-409. PubMed ID: 21979451 [TBL] [Abstract][Full Text] [Related]
16. GluN2D N-Methyl-d-Aspartate Receptor Subunit Contribution to the Stimulation of Brain Activity and Gamma Oscillations by Ketamine: Implications for Schizophrenia. Sapkota K; Mao Z; Synowicki P; Lieber D; Liu M; Ikezu T; Gautam V; Monaghan DT J Pharmacol Exp Ther; 2016 Mar; 356(3):702-11. PubMed ID: 26675679 [TBL] [Abstract][Full Text] [Related]
17. Effects of aberrant gamma frequency oscillations on prepulse inhibition. Jones NC; Anderson P; Rind G; Sullivan C; van den Buuse M; O'Brien TJ Int J Neuropsychopharmacol; 2014 Oct; 17(10):1671-81. PubMed ID: 24832766 [TBL] [Abstract][Full Text] [Related]
18. Relationship of resting brain hyperconnectivity and schizophrenia-like symptoms produced by the NMDA receptor antagonist ketamine in humans. Driesen NR; McCarthy G; Bhagwagar Z; Bloch M; Calhoun V; D'Souza DC; Gueorguieva R; He G; Ramachandran R; Suckow RF; Anticevic A; Morgan PT; Krystal JH Mol Psychiatry; 2013 Nov; 18(11):1199-204. PubMed ID: 23337947 [TBL] [Abstract][Full Text] [Related]
19. Glutamatergic Deficits in Schizophrenia - Biomarkers and Pharmacological Interventions within the Ketamine Model. Haaf M; Leicht G; Curic S; Mulert C Curr Pharm Biotechnol; 2018; 19(4):293-307. PubMed ID: 29929462 [TBL] [Abstract][Full Text] [Related]
20. Comparison of brain metabolic activity patterns induced by ketamine, MK-801 and amphetamine in rats: support for NMDA receptor involvement in responses to subanesthetic dose of ketamine. Duncan GE; Miyamoto S; Leipzig JN; Lieberman JA Brain Res; 1999 Oct; 843(1-2):171-83. PubMed ID: 10528123 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]